10 Reasons Why Third Party Pharma Manufacturing is Booming in India

India has emerged as a global pharmaceutical powerhouse, ranking third in the world by volume and fourteenth by value. Behind this astounding rise lies a revolutionary business model, Third Party Pharma Manufacturing. Commonly known as pharma contract manufacturing, this model allows pharma players to outsource the manufacture of healthcare products and medicines to specialized third party manufacturers.

Third party manufacturing pharma companies' growth in India is fuelled by several economic, strategic and operational benefits. The business is not only affordable but flexible, scalable, and expert as well, making it the perfect pick for startups as well as well-established pharma companies. Here are 10 strong reasons in this blog why third party manufacturing is growth-charting in India and how it's transforming the pharma industry.

Top Reasons for third party pharma manufacturing in India 

1. Cost-Effectiveness and Reduced Investment

Third party manufacturing possesses one of the strongest advantages when it comes to cost-effectiveness. Setting up a manufacturing unit entails massive capital investment—machinery, infrastructure, compliance certificates and skilled manpower. With the choice of a pharma third party manufacturing, companies can cut down incredibly on production while investing in brand creation, marketing, and distribution.

2. Rapid Market Penetration

Third party manufacturing companies of pharma make rapid market entry easier. Companies are able to launch new products without wasting time or going through the process of setting up the plant or obtaining regulatory approval. The speed gives them an edge over competitors in a fast-moving market.

Case Study: Chandigarh-based startup broadened its product portfolio from 20 to 80 SKUs within two years by partnering with third party manufacturing companies in North India.

3. Access to Advanced Technology and Qualified Expertise

Third party manufacturers invest heavily in advanced technologies, quality control systems, and qualified human resources. By working with such manufacturers, brands have access to the best infrastructure without ownership.

4. Facilitating Regulatory Compliance

It is complex to handle norms like WHO-GMP, ISO, and DCGI approval. The pharma third party manufacturing companies are already adhering to these norms, relieving partner brands of the regulatory infrastructure.

Insight: A 3rd party pharma manufacturing company globally compliant also offers international export avenues under the client's brand name.

5. Scalability and Production Flexibility

Business is all about change. Either scaling up production to meet market demand or scaling down in off-seasons, scalability is ensured by 3rd party manufacturing. This prevents overstocking and reduces risk.

When the COVID-19 pandemic happened, many companies shifted their focus towards immunity boosters and antivirals. Third party manufacturing companies were quick in restructuring their manufacturing units accordingly.

6. Focus on Core Competencies

By outsourcing product manufacturing, companies can concentrate on core activities like research, branding, and market creation. This may result in a stronger brand identity and enhanced market planning.

7. Increased Export Possibilities

India is a major exporter of pharmaceuticals. With collaborations with pharma contract manufacturing partners who are export qualified, companies can penetrate regulated markets such as the US, UK, Africa, and Southeast Asia.

Stat: Indian pharma exports during FY2023 stood at over $25 billion, with a major portion thereof being from third party manufacturing companies.

8. Quick Time-to-Market

It will take years to roll out a new product if one chooses to build its manufacturing facility. Third party pharma manufacturing shortens the time by a significant amount, resulting in quicker rollouts.

Case Study: A pharma third party manufacturing company helped a nutraceutical company launch 12 SKUs in four months, tapping into market demand patterns promptly.

9. Product Diversification and Innovation

Third party manufacturers have long product ranges ranging from tablets and capsules to injectables and syrups. This helps companies diversify products without investments in individual lines of manufacture.

A company can supply general medicine as well as dermatology products with assistance from expert third party pharma manufacturing companies placed across the country.

10. Government Support and Industrial Clusters

The Indian government recognizes the potential for pharma contract manufacturing and has started enabling policies, subsidies, and industry clusters. These pharma clusters, e.g., at Baddi, Hyderabad, and Sikkim, offer combined infrastructure for third party manufacturers.

Policy Spotlight: The Production Linked Incentive (PLI) policy for drugs encourages more investment in manufacturing units, again nudging the third party manufacturing ecosystem.

Conclusion

The spectacular growth of Indian third party pharma manufacturing is not a coincidence. It is the result of strategic business advantages, government initiatives, technical advancements, and evolving needs of the pharmaceutical sector. With partnership from a reliable pharma third party manufacturer, pharma businesses—new entrants or established ones, can achieve economies of scale, agility, and sustainable growth.

With India continuing to cement its status as the "Pharmacy of the World," the future of third party manufacturing companies will be more critical than ever. This successful industry is set to revolutionize the way pharma products are produced, marketed and distributed, both locally in India and globally.


Must Read: 

Exploring Growth of Third Party Product Manufacturing in Pharma Industry
How Third Party Manufacturing Helps Cut Costs and Boost Efficiency?